Search for:

In brief

The North America Trade Secrets Practice presents a closer look at the DOJ’s China Initiative, which was announced in 2018, and what it means for investigating and prosecuting claims of trade secret misappropriation that involve a China aspect. How, if at all, would a new presidential administration be likely to change the Initiative? What has happened so far, and what are the trends?


Hear from North America Trade Secret Practice Members Bradford Newman, Katelyn Sprague, Christine Streatfeild, and Jessica Nall, including Jessica’s insight from her experience in defending a charged party in one of the DOJ’s earliest prosecutions under the China Initiative.

Click here to view video chat

Author

Christine Streatfeild is a partner in the IPTech Practice Group. She has a broad range of trade, regulatory, and litigation experience, most frequently representing clients in antidumping and countervailing duty cases, safeguard measures, duties imposed for national security purposes (Section 232 duties), and Section 337 intellectual property and trade secrets disputes. She appears before the US International Trade Commission (ITC), US Department of Commerce (DOC), and the federal courts. She also routinely advises companies regulated by the Food and Drug Administration (FDA) on issues affecting mergers, acquisitions, licensing, and compliance. Prior to joining Baker McKenzie, Ms. Streatfeild served as the acting deputy director of the Generalized System of Preferences (GSP) and in the Environment and Natural Resources division of the Office of the United States Trade Representative. She has also served as an adjunct professor at the Krieger School, Johns Hopkins University, where she taught Global Trade, Policy and Competition.

Author

Katelyn is an Associate in the Litigation and Government Enforcement Practice Group assisting clients in complex civil litigation and government enforcement matters. Prior to joining the firm, Katelyn worked at a litigation firm where she focused on restrictive covenant, products liability, and shareholder dispute litigation.